155 related articles for article (PubMed ID: 14758523)
1. When is recalcitrant pyoderma gangrenosum truly recalcitrant?
Barnabé C; Hurst L; Alowami S
J Cutan Med Surg; 2003; 7(5):387-9. PubMed ID: 14758523
[TBL] [Abstract][Full Text] [Related]
2. Recalcitrant pyoderma gangrenosum treated with thalidomide.
Federman GL; Federman DG
Mayo Clin Proc; 2000 Aug; 75(8):842-4. PubMed ID: 10943240
[TBL] [Abstract][Full Text] [Related]
3. Treatment of severe recalcitrant pyoderma gangrenosum with ustekinumab.
Low ZM; Mar A
Australas J Dermatol; 2018 May; 59(2):131-134. PubMed ID: 29205260
[TBL] [Abstract][Full Text] [Related]
4. Recalcitrant pyoderma gangrenosum: treatment with thalidomide.
Hecker MS; Lebwohl MG
J Am Acad Dermatol; 1998 Mar; 38(3):490-1. PubMed ID: 9520035
[No Abstract] [Full Text] [Related]
5. Infliximab as a treatment for recalcitrant pyoderma gangrenosum.
Singh M; Andrew SM; Lear JT
Clin Exp Dermatol; 2004 Mar; 29(2):196-7. PubMed ID: 14987282
[No Abstract] [Full Text] [Related]
6. Refractory pyoderma gangrenosum treated with infliximab in an infant.
Campos-Muñoz L; Conde-Taboada A; Aleo E; Toledano E; López-Bran E
Clin Exp Dermatol; 2014 Apr; 39(3):336-9. PubMed ID: 24635074
[TBL] [Abstract][Full Text] [Related]
7. Pyoderma gangrenosum in an infant: A case report and review of the literature.
Crouse L; McShane D; Morrell DS; Wu EY
Pediatr Dermatol; 2018 Sep; 35(5):e257-e261. PubMed ID: 29656404
[TBL] [Abstract][Full Text] [Related]
8. Treatment of idiopathic pyoderma gangrenosum with infliximab: induction dosing regimen or on-demand therapy?
Adişen E; Oztaş M; Gürer MA
Dermatology; 2008; 216(2):163-5. PubMed ID: 18216480
[TBL] [Abstract][Full Text] [Related]
9. Severe recalcitrant pyoderma gangrenosum treated with infliximab.
Kaur MR; Lewis HM
Br J Dermatol; 2005 Sep; 153(3):689-91. PubMed ID: 16120178
[No Abstract] [Full Text] [Related]
10. Successful treatment of recalcitrant pyoderma gangrenosum with infliximab complicated by tuberculosis despite negative screening tests.
Uthman I; El-Sayad J; Sharara A
Clin Exp Dermatol; 2005 May; 30(3):294. PubMed ID: 15807693
[No Abstract] [Full Text] [Related]
11. Treatment of refractory pyoderma gangrenosum with infliximab in a 17-month-old boy.
Bobbitt SA; Klaus EM; Stringer E; Chowdhury D; Finlayson L
Dermatol Online J; 2016 Apr; 22(4):. PubMed ID: 27617462
[TBL] [Abstract][Full Text] [Related]
12. Anakinra for recalcitrant pyoderma gangrenosum.
O'Connor C; Gallagher C; Hollywood A; Paul L; O'Connell M
Clin Exp Dermatol; 2021 Dec; 46(8):1558-1560. PubMed ID: 34137070
[TBL] [Abstract][Full Text] [Related]
13. Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome.
Stichweh DS; Punaro M; Pascual V
Pediatr Dermatol; 2005; 22(3):262-5. PubMed ID: 15916580
[TBL] [Abstract][Full Text] [Related]
14. Treatment of pyoderma gangrenosum with methotrexate.
Teitel AD
Cutis; 1996 May; 57(5):326-8. PubMed ID: 8726713
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of pyoderma gangrenosum (PG): an updated review.
Braswell SF; Kostopoulos TC; Ortega-Loayza AG
J Am Acad Dermatol; 2015 Oct; 73(4):691-8. PubMed ID: 26253362
[TBL] [Abstract][Full Text] [Related]
16. Keratin Gel as an Adjuvant in the Treatment of Recalcitrant Pyoderma Gangrenosum Ulcers: A Case Report.
Paulsen E; Bygum A
Acta Derm Venereol; 2019 Feb; 99(2):234-235. PubMed ID: 30393816
[No Abstract] [Full Text] [Related]
17. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.
Regueiro M; Valentine J; Plevy S; Fleisher MR; Lichtenstein GR
Am J Gastroenterol; 2003 Aug; 98(8):1821-6. PubMed ID: 12907338
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment with ustekinumab and vacuum-assisted closure therapy in recalcitrant myelodysplastic syndrome-associated pyoderma gangrenosum: case report and literature review.
Nieto D; Sendagorta E; Rueda JM; Herranz P
Clin Exp Dermatol; 2019 Jan; 44(1):116-119. PubMed ID: 29851121
[No Abstract] [Full Text] [Related]
19. Pyoderma gangrenosum: clinical characteristics, associated diseases, and responses to treatment in a retrospective cohort study of 31 patients.
Vacas AS; Torre AC; Bollea-Garlatti ML; Warley F; Galimberti RL
Int J Dermatol; 2017 Apr; 56(4):386-391. PubMed ID: 28295267
[TBL] [Abstract][Full Text] [Related]
20. Pyoderma gangrenosum successfully treated with cyclosporin A.
V'lckova-Laskoska MT; Laskoski DS; Caca-Biljanovska NG; Darkoska JS
Adv Exp Med Biol; 1999; 455():541-5. PubMed ID: 10599396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
